{"database": "lobbying", "table": "lobbying_activities", "rows": [[2469290, "903c4911-dfa2-45da-8cb4-5e6ea1e11711", "Q2", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "ASTRAZENECA", 2020, "second_quarter", "PHA", "Drug coverage & reimbursement\n\nno specific bills, Import Safety, drug development policy, drug shortages, supply chain integrity, Innovation, reimportation, transparency, 340B, pay for delay\n\nH.R. 3 - Lower Drug Costs Now Act\nS. 2543 - Prescription Drug Pricing Reduction Act\nS. 1895 - Lower Health Care Costs Act\nS. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act\nS. 3129 - Lower Costs, More Cures Act of 2019", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2020-07-16T15:33:59.117000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2469290"], "units": {}, "query_ms": 23.429995053447783, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}